Login

A RADICAL INVESTMENT PLATFORM RESHAPING THE RELATIONSHIP BETWEEN FOUNDERS AND CAPITAL|Khaled Talhouni, Managing Partner, Nuwa Capital 00:10:00

Share On Facebook Share On Twitter

Venture Capitalist investing in emerging markets

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Insights into Mexico's Fibra Market: A Conversation with Miguel Aliaga, CFO of Fibra Inn|Managing Director,Acadia Realty Trust
00:10:00
investing in high potential B2B technology startups|Caroline Casson,Partner,VITALIZE Venture Capital
00:10:00
Uranium's Bright Future: Insights from Elevate Uranium's CEO Murray Hill
00:10:00
Lake Resources' Innovative Approach to Clean Lithium Production
00:10:00
Insights into Asset Management and Market Outlook | B.Gopkumar, CEO ,Axis Mutual Fund.
00:10:00
How Feelings Guide Music: Channeling Emotion in Collaboratio|Rick Rubin, Professor, Washington Healthcare Forum
00:10:00
CEO Rosario Pingaro Discusses the Future-Proof Vision of Convergenze: A Leading Multiutility | Rosario Pingaro, CEO, Convergenze SpA Società Benefit.
00:10:00
Geoffrey Martin: President & CEO, CCL Industries Inc. | Geoffrey T. Martin - President and Chief Executive Officer of CCL Industries
00:10:00
Building a Global Investment Powerhouse: Stephen Schwarzman on Leading Blackstone | Stephen A. Schwarzman, CEO , The Blackstone Group Inc.
00:10:00
American West Metals: 2023 Plans for the High-Grade Storm Copper Project in Nunavut | Dave O'Neill, CEO, American West Metals Ltd.
00:10:00
Kyndryl CEO Martin Schroeter shared his insights on a significant day shortly after the Opening Bell.
00:10:00
Kasbah Resources: Developing the Advanced Ashramsh Tungsten Project in Morocco

© 2026 Nehu